Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,593
Total Claims
$728K
Drug Cost
558
Beneficiaries
$1,305
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-94%
Opioid rate vs peers
0.1% vs 2.2% avg
-7%
Cost per patient vs peers
$1,305 vs $1,411 avg
+58%
Brand preference vs peers
16.8% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
15
Opioid Claims
$74
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,904 claims · $590K
Generic: 9,409 claims · $132K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 166 | $96K |
| Insulin Nph Hum/Reg Insulin Hm | 173 | $58K |
| Empaglifloz/Linaglip/Metformin | 77 | $51K |
| Empagliflozin/Metformin Hcl | 53 | $34K |
| Dapaglifloz Propaned/Metformin | 61 | $32K |
| Budesonide/Formoterol Fumarate | 72 | $28K |
| Linagliptin/Metformin Hcl | 54 | $28K |
| Sitagliptin Phos/Metformin Hcl | 35 | $26K |
| Insulin Glargine,hum.Rec.Anlog | 70 | $22K |
| Levothyroxine Sodium | 324 | $17K |
| Rivaroxaban | 24 | $16K |
| Insulin Lispro Protamin/Lispro | 21 | $15K |
| Dapagliflozin Propanediol | 24 | $15K |
| Empagliflozin/Metformin Hcl | 24 | $14K |
| Ticagrelor | 33 | $13K |
Prescribing Profile
Patient Profile
75
Avg Age
57%
Female
1.45
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data